update
Mitsui confirms increased Arch Pharmalabs investment; wants to build API biz
Mitsui & Co has upped its stake in Indian API maker Arch Pharmalabs in an effort to expand its CMO business.
Archives for January 17, 2013
XD cell culture technology: DSM boosted by Amgen license
DSM hints at high yield and cost-cutting benefits in licensing its cell growth technology to Amgen.
Some Indian Drug Exporters Skirt New Bar Code Requirements
Indian pharmaceutical exporters now need to apply barcodes on their secondary packages as part of an effort to increase safety and traceability, but some have avoided the requirements, experts say.
SFDA ups rewards for people who shop illegal drugmakers
People who report illegal drug production could now earn up to 300,000 Yuan ($48,250) under a revised reward scheme launched by the SFDA.
UK Health Committee Calls for All Clinical Trial Data to be Public
The UK government’s health committee is calling for all clinical trial information to be in the public domain but industry push back is expected, experts say.
Foreign Generic Drug, API Manufacturers Hit Hardest by GDUFA Fees
Foreign generic drug and API manufacturers will have to pay $15,000 more than their US counterparts because of additional costs required for the US Food and Drug Administration (FDA) to inspect the overseas facilities.